Delivery Order SPE2DB25D3306-SPE2DB25FUAZK

Award Date 2/28/25
Potential Completion Date 3/3/25
Potential Value $4.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on October 17, 2024, with a ceiling value of $5,816.70 and a completion date of October 18, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued...
The federal contract award is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on August 25, 2022 with a ceiling value of $11,841.12. This contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through...
This federal contract award is for the pharmaceutical product TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, with a ceiling value of $2,827.44. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The award is a delivery order contract with a firm fixed price pricing type. The period of performance extends through May 29, 2025. This contract is not designated as a set-aside....
This federal contract award is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,685.70 and a completion date of November 8, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, as a delivery order under an existing Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a wide range of pharmaceutical products and...
This federal contract award is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,777.08 and an ultimate completion date of July 17, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between...
This federal contract award is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The contract, with a ceiling value of $2,322.24, was awarded to Amerisourcebergen Drug Corp's Corporate Office division on May 16, 2024, with a completion date of May 17, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued up to...
This federal contract award is for the delivery of the pharmaceutical product TRULICITY 1.5 MG/0.5 ML PEN 0.5ML to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract has a ceiling value of $3,077.73 and is a Firm Fixed Price Delivery Order, with an ultimate completion date of June 26, 2024. Amerisourcebergen holds a larger Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $4,967.82 and a completion date of February 3, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This federal contract award is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $6,006.00 and an ultimate completion date of January 14, 2025. It is a firm fixed-price delivery order contract awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not designated with a set-aside requirement....
  • SPE2DB25D3306
    Indefinite Delivery Contract
  • SPE2DB25D3306-SPE2DB25FUAZK
    Delivery Order

This federal contract award is for the pharmaceutical product TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, with a ceiling value of $4,249.39. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on February 28, 2025, with an ultimate completion date of March 3, 2025.

The contract is a Delivery Order awarded by the Defense Logistics Agency (DLA), a defense agency, under a pre-existing Indefinite Delivery Contract (IDC) valued at $999,999,999 that runs through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/30/25, 10:10 AM